Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 2/2017

04.11.2016 | Original Article

Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma

verfasst von: Shenghua Hao, Ping Fan, Shaofei Chen, Caixue Tu, Chidan Wan

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background and Objectives

Intrahepatic recurrence after hepatectomy for hepatocellular carcinoma (HCC) includes intrahepatic metastasis (IM) and multicenter occurrence (MO). The risk factors for these two types of intrahepatic recurrence have not been well defined.

Methods

The type of intrahepatic recurrence was determined based on histopathological features of 93 HCC patients who underwent a repeat hepatectomy for recurrent HCC. Various clinical and pathological factors were analyzed to define distinct risk factors for different types of intrahepatic recurrence.

Results

The recurrence rates at 1, 2, 3, 5, and 8 years postoperatively were 22.4, 42.9, 61.2, 85.7, and 100 %, respectively, in patients with IM and 5.0, 25.0, 45.5, 67.5, and 100 %, respectively, in patients with MO (p = 0.005). A total of 16 clinical and pathological factors were tested in univariable and multivariable analyses. We found that large-size tumor (>5 cm), multiple tumors (two or more), and vascular invasion were significantly associated with IM recurrence, and liver cirrhosis and Ishak hepatic inflammatory activity were highly associated with MO recurrence. In addition, blood transfusion and a high hepatitis B virus (HBV)-DNA load (>2000 IU/ml) were independent risk factors common to both IM and MO recurrences.

Conclusions

IM and MO recurrences were associated with distinct risk factors, while blood transfusion and high HBV-DNA load (>2000 IU/ml) were independent risk factors common to both IM and MO recurrences.
Literatur
1.
Zurück zum Zitat Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y, Belghiti J. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J SurgOncol 2004, 85:36–41. Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y, Belghiti J. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J SurgOncol 2004, 85:36–41.
2.
Zurück zum Zitat Chen PJ, Chen DS, Lai MY, et al. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology. 1989;96:527–9.CrossRefPubMed Chen PJ, Chen DS, Lai MY, et al. Clonal origin of recurrent hepatocellular carcinomas. Gastroenterology. 1989;96:527–9.CrossRefPubMed
3.
Zurück zum Zitat Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, Maeda T, Shirabe K, Nishizaki K, Sugimachi K. Prognosis of recurrent hepatocellularcarcinoma: a 10-year surgical experience in Japan, Gastroenterology 1996;111:720–726.CrossRefPubMed Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, Maeda T, Shirabe K, Nishizaki K, Sugimachi K. Prognosis of recurrent hepatocellularcarcinoma: a 10-year surgical experience in Japan, Gastroenterology 1996;111:720–726.CrossRefPubMed
4.
Zurück zum Zitat Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Tkayama T, Kawasaki S. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–7.CrossRefPubMed Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Tkayama T, Kawasaki S. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–7.CrossRefPubMed
5.
Zurück zum Zitat Okada S, Ishii H, Nose H, Okusaka T, Kyogoku A, Yoshimori M, Sakamoto M, Hirohashi S: Intratumoral DNA heterogeneity of small hepatocellular carcinoma. Cancer 1995;75:444–450.CrossRefPubMed Okada S, Ishii H, Nose H, Okusaka T, Kyogoku A, Yoshimori M, Sakamoto M, Hirohashi S: Intratumoral DNA heterogeneity of small hepatocellular carcinoma. Cancer 1995;75:444–450.CrossRefPubMed
6.
Zurück zum Zitat Saeki R, Nagai H, Kaneko S, Unoura M, Yamanaka N, Okamoto E, Kobayashi K, Matsubara K: Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning. J Hepatol 2000;33:99–105.CrossRefPubMed Saeki R, Nagai H, Kaneko S, Unoura M, Yamanaka N, Okamoto E, Kobayashi K, Matsubara K: Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning. J Hepatol 2000;33:99–105.CrossRefPubMed
7.
Zurück zum Zitat Friemel J, Rechsteiner M, Frick L, Böhm F, Struckmann K, Egger M, Moch H, Heikenwalder M, Weber A: Intratumor heterogeneity in hepatocellular carcinoma. Clin Cancer Res 2015;21:1951–1961.CrossRefPubMed Friemel J, Rechsteiner M, Frick L, Böhm F, Struckmann K, Egger M, Moch H, Heikenwalder M, Weber A: Intratumor heterogeneity in hepatocellular carcinoma. Clin Cancer Res 2015;21:1951–1961.CrossRefPubMed
8.
Zurück zum Zitat Li Q, Wang J,. Juzi JT, Sun Y, Zheng H, Cui YL, Li HX, Hao XS. Clonality Analysis for Multicentric Origin and Intrahepatic Metastasis in Recurrent and Primary Hepatocellular Carcinoma. J Gastrointest Surg 2008;12:1540–1547.CrossRefPubMed Li Q, Wang J,. Juzi JT, Sun Y, Zheng H, Cui YL, Li HX, Hao XS. Clonality Analysis for Multicentric Origin and Intrahepatic Metastasis in Recurrent and Primary Hepatocellular Carcinoma. J Gastrointest Surg 2008;12:1540–1547.CrossRefPubMed
9.
Zurück zum Zitat Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7: 462–503.CrossRefPubMed Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7: 462–503.CrossRefPubMed
10.
Zurück zum Zitat Greene FL, Page DL, Fleming ID, et al. (6th eds.). “In AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual.” New York: Springer: New York, 2002. Greene FL, Page DL, Fleming ID, et al. (6th eds.). “In AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual.” New York: Springer: New York, 2002.
11.
Zurück zum Zitat Arii S, Monden K, Niwano M, Furutani M, Mori A, Mizumoto M, Imamura M. Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg.1998;5:86–92.CrossRefPubMed Arii S, Monden K, Niwano M, Furutani M, Mori A, Mizumoto M, Imamura M. Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepatobiliary Pancreat Surg.1998;5:86–92.CrossRefPubMed
12.
Zurück zum Zitat Matsuda M, Fujii H, Kono H, Matsumoto Y. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J Hepatobiliary Pancreat Surg. 2001;8:353–9.CrossRefPubMed Matsuda M, Fujii H, Kono H, Matsumoto Y. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J Hepatobiliary Pancreat Surg. 2001;8:353–9.CrossRefPubMed
13.
Zurück zum Zitat Feo F, Pascale RM. Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?. Ann Transl Med 2015;3(1):4–8.PubMedPubMedCentral Feo F, Pascale RM. Multifocal hepatocellular carcinoma: intrahepatic metastasis or multicentric carcinogenesis?. Ann Transl Med 2015;3(1):4–8.PubMedPubMedCentral
14.
Zurück zum Zitat Portolani N, Coniglio A, Ghidoni S, Giovanelli M, BenettiA, Tiberio GA, Giulini SM. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243:229–35. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, BenettiA, Tiberio GA, Giulini SM. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243:229–35.
15.
Zurück zum Zitat Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, et al. Liver resection for transplantable hepatocellularcarcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 2009;250:738–746. Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, et al. Liver resection for transplantable hepatocellularcarcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 2009;250:738–746.
16.
Zurück zum Zitat Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002;235:373–382CrossRefPubMedPubMedCentral Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002;235:373–382CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Poon RT, Fan ST, Wong J. Risk factors, prevention, management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000, 232:10–24.CrossRef Poon RT, Fan ST, Wong J. Risk factors, prevention, management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000, 232:10–24.CrossRef
18.
Zurück zum Zitat Cucchetti A, Piscaglia F, Caturelli E, Benvegnu L, Vivarelli M, Ercolani G, Cescon M, Ravaioli M, Grazi GL, Bolondi L, Pinna AD. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann SurgOncol. 2009;16:413–22 Cucchetti A, Piscaglia F, Caturelli E, Benvegnu L, Vivarelli M, Ercolani G, Cescon M, Ravaioli M, Grazi GL, Bolondi L, Pinna AD. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. Ann SurgOncol. 2009;16:413–22
19.
Zurück zum Zitat Wang J, Li Q, Sun Y, Zheng H, Cui Y, Li H, Zhou H, Hao X. Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV. Surgical Oncology 2009;18:25–30.CrossRefPubMed Wang J, Li Q, Sun Y, Zheng H, Cui Y, Li H, Zhou H, Hao X. Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV. Surgical Oncology 2009;18:25–30.CrossRefPubMed
20.
Zurück zum Zitat Makino Y, Yamanoi A, Kimoto T, Nazmy El-Assal O, Kohno H, Nagasue N. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterology 2000;95:1294–1300.CrossRef Makino Y, Yamanoi A, Kimoto T, Nazmy El-Assal O, Kohno H, Nagasue N. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterology 2000;95:1294–1300.CrossRef
21.
Zurück zum Zitat van Gulik TM, de Graaf W, Dinant S, Busch OR, Gouma DJ. Vascular Occlusion Techniques during Liver Resection. Dig Surg 2007; 24:274–281.CrossRefPubMed van Gulik TM, de Graaf W, Dinant S, Busch OR, Gouma DJ. Vascular Occlusion Techniques during Liver Resection. Dig Surg 2007; 24:274–281.CrossRefPubMed
22.
Zurück zum Zitat Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Mizuno S, Makuuchi M. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994;115(3):303–9.PubMed Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N, Mizuno S, Makuuchi M. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994;115(3):303–9.PubMed
23.
Zurück zum Zitat Blajchman MA. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. 1998; Vox Sang 74Suppl 2 315–319. Blajchman MA. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. 1998; Vox Sang 74Suppl 2 315–319.
24.
Zurück zum Zitat Ydy LR, Slhessarenko N, de Aguilar-Nascimento JE. Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection. World J Surg 2007; 31: 2044–2051.CrossRefPubMed Ydy LR, Slhessarenko N, de Aguilar-Nascimento JE. Effect of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response after colorectal cancer resection. World J Surg 2007; 31: 2044–2051.CrossRefPubMed
25.
Zurück zum Zitat Goubran H, Sabry W, Kotb R, Seghatchian J, Burnouf T. Platelet microparticles and cancer: an intimate cross-talk. Transfus Apher Sci 2015;53(2):168–172.CrossRefPubMed Goubran H, Sabry W, Kotb R, Seghatchian J, Burnouf T. Platelet microparticles and cancer: an intimate cross-talk. Transfus Apher Sci 2015;53(2):168–172.CrossRefPubMed
26.
Zurück zum Zitat Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21(6):327–348.CrossRefPubMed Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21(6):327–348.CrossRefPubMed
28.
Zurück zum Zitat Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65–73.CrossRefPubMed Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65–73.CrossRefPubMed
29.
Zurück zum Zitat Muroyama R, Kato N, Yoshida H, Otsuka M, Moriyama M, Wang Y. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. J Hepatol 2006;45:805–812.CrossRefPubMed Muroyama R, Kato N, Yoshida H, Otsuka M, Moriyama M, Wang Y. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. J Hepatol 2006;45:805–812.CrossRefPubMed
30.
31.
Zurück zum Zitat Volpes R, van den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology1990; 12: 59–65.CrossRefPubMed Volpes R, van den Oord JJ, Desmet VJ. Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology1990; 12: 59–65.CrossRefPubMed
32.
Zurück zum Zitat Sze KM, Chu GK, Lee JM, Ng OL. C-Terminal Truncated Hepatitis B Virus X Protein Is Associated With Metastasis and Enhances Invasiveness by C-Jun/Matrix Metalloproteinase Protein 10 Activation in Hepatocellular Carcinoma. Hepatology 2013;57:131–139.CrossRefPubMed Sze KM, Chu GK, Lee JM, Ng OL. C-Terminal Truncated Hepatitis B Virus X Protein Is Associated With Metastasis and Enhances Invasiveness by C-Jun/Matrix Metalloproteinase Protein 10 Activation in Hepatocellular Carcinoma. Hepatology 2013;57:131–139.CrossRefPubMed
Metadaten
Titel
Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma
verfasst von
Shenghua Hao
Ping Fan
Shaofei Chen
Caixue Tu
Chidan Wan
Publikationsdatum
04.11.2016
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 2/2017
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-016-3311-z

Weitere Artikel der Ausgabe 2/2017

Journal of Gastrointestinal Surgery 2/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.